Quoix E, Fraser R, Wolkove N, Finkelstein H, Kreisman H
Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada.
Cancer. 1990 Aug 1;66(3):577-82. doi: 10.1002/1097-0142(19900801)66:3<577::aid-cncr2820660328>3.0.co;2-y.
Small cell lung cancer (SCLC) rarely presents radiographically as a solitary pulmonary nodule (SPN). Twenty-five patients with this feature were identified among 408 individuals with SCLC at McGill University (Montreal, Quebec) from 1979 through 1984. Of these, 15 (60%) were confirmed on pathologic review as SCLC (ten intermediate cell, four oat cell, one indeterminate). Pathologic review of a control group comprising 24 other limited-disease patients who were long-term survivors (greater than 20 months) confirmed 20 (84%) as SCLC (eight intermediate cell, 12 oat cell). Ten of the 15 patients with SPN were resected whereas five had chemotherapy and/or radiotherapy as primary treatment. Postoperative chemotherapy was administered to most of the resected patients. The median survival of the 15 patients with SPN was 24 months, a significantly longer survival than the other patients with SCLC. This improved prognosis in patients with SPN may be due to smaller initial tumor burden or to a fundamental biologic difference between SPN and other forms of SCLC.
小细胞肺癌(SCLC)在影像学上很少表现为孤立性肺结节(SPN)。1979年至1984年期间,在麦吉尔大学(蒙特利尔,魁北克)的408例小细胞肺癌患者中,有25例具有这一特征。其中,15例(60%)经病理检查确诊为小细胞肺癌(10例为中间细胞型,4例为燕麦细胞型,1例不确定)。对由24例其他局限性疾病的长期存活患者(超过20个月)组成的对照组进行病理检查,确诊20例(84%)为小细胞肺癌(8例为中间细胞型,12例为燕麦细胞型)。15例孤立性肺结节患者中有10例行手术切除,而5例以化疗和/或放疗作为主要治疗手段。大多数接受手术切除的患者术后接受了化疗。15例孤立性肺结节患者的中位生存期为24个月,显著长于其他小细胞肺癌患者。孤立性肺结节患者预后的改善可能是由于初始肿瘤负荷较小,或者是由于孤立性肺结节与其他形式的小细胞肺癌之间存在根本的生物学差异。